Bayer settles Yasmin related class action

bouton croixBayer AG has announced a settlement with plaintiffs who filed a lawsuit claiming they sustained gallbladder harm and pain after using Yasmin and Yaz oral contraceptives.  Under the terms of the settlement, Bayer will pay $24 million to settle gallbladder injury lawsuits combined in the U.S. District Court for the Southern District of Illinois, in addition to courts in California, New Jersey and Pennsylvania.

Bayer will give $2,000 to plaintiffs who experienced gallbladder injuries and $3,000 to patients who had their gallbladders eradicated.  Despite the settlement, Bayer said that it did not believe Yaz and Yasmin birth control pills increase the chances of receiving gallbladder disease, compared to different oral contraceptives.

Additionally, Bayer agreed to pay $1 billion to settle complaints filed by 4,800 women who claimed that Yasmin and Yaz created blood clots which caused heart attacks, strokes or other injuries.

In April 2012, the Food and Drug Administration required additional information on birth control labels, including Yasmin and Yaz, to emphasize blood clot warnings.

Steve Larson
An experienced trial lawyer who handles both hourly and contingent fee cases, Steve has expertise in class actions, antitrust litigation, securities litigation, corporate disputes, intellectual property disputes, unfair competition claims, and disputes involving family wealth. Steve regularly represents individuals and businesses in federal and state court and has obtained class-wide recovery in multiple class actions. A veteran practitioner, Steve's clients value his creative approach to resolving complex litigation matters.


Share on facebook
Share on twitter
Share on google
Share on linkedin

Legal Disclaimer

The information contained in this blog does not constitute legal advice, and does not create an attorney-client relationship. We make no claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained in or linked to this blog.